EW:NYSE
Edwards Lifesciences Corp
US$85,15
arrow_downward
-0,04%(-0,030) 1D
US$85,15
0,00% (0,00)
bedtimeAfter hours
Closed: 2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 05 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
US$85,52
High
US$86,48
Low
US$84,66
Mkt. cap
49,08 ຕື້
Avg. vol.
3,23 ລ້ານ
Volume
2,41 ລ້ານ
P/E ratio
49,26
52-wk high
US$96,29
52-wk low
US$72,30
EPS
US$1,73
Beta
0,87
Shares outstanding
576,40 ລ້ານ
No. of employees
16 ພັນ
Open
US$85,52
High
US$86,48
Low
US$84,66
Mkt. cap
49,08 ຕື້
Avg. vol.
3,23 ລ້ານ
Volume
2,41 ລ້ານ
P/E ratio
49,26
52-wk high
US$96,29
52-wk low
US$72,30
EPS
US$1,73
Beta
0,87
Shares outstanding
576,40 ລ້ານ
No. of employees
16 ພັນ
News stories
From web sources and news partners
Benzinga
·
9 ຊົ່ວໂມງກ່ອນ
Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve
Benzinga
·
15 ຊົ່ວໂມງກ່ອນ
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 ພັນ
Founded1958
Headquartersເອີວິນ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorMedical device
Websiteedwards.com